Charles Divita III Sells $115K of Teladoc Health Inc (TDOC) — SEC Form 4, Sep 03, 2026

Open-Market Net Sale · SEC Form 4

−$115,478

Equity position changed by +6.0%

Reporting Owner

Charles Divita III

CEO

TXN 2026-09-02 · FILED 2026-09-03

Equity Position 459K sh 432,949 → 458,865

Equity Change +6.0% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Teladoc Health Inc

TDOC CIK 0001477449

Reporting Owner

Name	Relationship
Charles Divita III CIK 0001347535	Director CEO

Charles Divita III at Teladoc Health Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $1,035,222

More from this insider at Teladoc Health Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2026-09-01	M - Exercise	42,277 A		—	456,899	Direct
Common StockF2	2026-09-01	M - Exercise	1,966 A		—	458,865	Direct
Common StockF3	2026-09-02	S - Sale	18,327 D	$6.30	-$115,478	440,538	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Restricted Stock UnitsF1 F4 F4		2026-09-01	M - Exercise	42,277 D	$0.00		42,277 Common Stock	Direct
Performance Stock UnitsF2 F5 F5		2026-09-01	M - Exercise	1,966 D	$0.00		1,966 Common Stock	Direct

Footnotes (5)

F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Show more
F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Show more
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Show more
F4: On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Show more
F5: On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Teladoc Health Inc

GET /v1/forms/4/0001347535-26-000009 API docs